Urgent.News

What's breaking now, across thousands of outlets.

Business

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

We haven't written up this one. The New York Times has the full story — the link below goes straight to it.

Read the original at nytimes.com →

More in Business

Brazil Slams US Tariffs as Unjustified

Brazil on Monday reiterated its dissatisfaction with U.S. tariffs on Brazilian goods.

  • Brazil protests U.S. tariffs on Brazilian products as unjustified.
  • Foreign Minister Mauro Vieira and Development Minister Marcio Elias Rosa voice grievances.
  • Both nations commit to ongoing negotiations and ministerial assessment.

More from Tuesday 1 September →